Search Within

Matthew David Hellmann

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (9)
  2. Molecular Imaging and Therapy Service (9)
  3. Radiology, Department of (9)
  4. Solid Tumor Oncology Division (9)
  5. Thoracic Oncology (9)
  6. GSK Faculty (6)

More Groups

People
  1. Jamie Chaft (5)
  2. Mark Kris (5)
  3. James Harding (4)
  4. Jedd Wolchok (4)
  5. Mark Dunphy (4)
  6. Michael Postow (4)

More People

Years
  1. 2022 (2)
  2. 2020 (2)
  3. 2018 (2)
  4. 2016 (1)
  5. 2014 (1)
  6. 2013 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Journal of Nuclear Medicine (2)
  3. Journal of Thoracic Oncology (2)
  4. Clinical Cancer Research (1)
  5. Journal for ImmunoTherapy of Cancer (1)
  6. Nature Medicine (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Elsevier Inc. (2)
  3. Society of Nuclear Medicine (2)
  4. American Association for Cancer Research (1)
  5. Biomed Central Ltd (1)
  6. Nature Publishing Group (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • CD8-targeted PET imaging of tumor-infiltrating T cells in patients with cancer: A phase I first-in-humans study of (89)Zr-Df-IAB22M2C, a radiolabeled anti-CD8 minibody
    Journal Article

    Farwell, M. D.; Gamache, R. F.; Babazada, H.; Hellmann, M. D.; Harding, J. J.; Korn, R.; Mascioni, A.; Le, W.; Wilson, I.; Gordon, M. S.; more...
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC
    Journal Article

    Hellmann, M. D.; Nabet, B. Y.; Rizvi, H.; Chaudhuri, A. A.; Wells, D. K.; Dunphy, M. P. S.; Chabon, J. J.; Liu, C. L.; Hui, A. B.; Arbour, K. C.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • First-in-humans imaging with (89)Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: Preliminary pharmacokinetics, biodistribution, and lesion targeting
    Journal Article

    Pandit-Taskar, N.; Postow, M. A.; Hellmann, M. D.; Harding, J. J.; Barker, C. A.; O'Donoghue, J. A.; Ziolkowska, M.; Ruan, S.; Lyashchenko, S. K.; Tsai, F.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Imaging of tumor infiltrating T cells with an anti-CD8 minibody (Mb) 89Zr-IAB22M2C, in advanced solid tumors
    Meeting Abstract

    Postow, M. A.; Harding, J. J.; Hellmann, M. D.; Gordon, M. S.; Tsai, F.; Donoghue, J. A. O.; Lewis, J. S.; Wu, A. M.; Le, W.; Korn, R. L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Imaging of tumor infiltrating T cells with an anti-CD8 minibody 89Zr-IAB22M2C in advanced solid tumors: A phase I first-in-human study
    Meeting Abstract

    Gordon, M. S.; Tsai, F.; Postow, M.; Hellmann, M.; Harding, J. J.; Korn, R. L.; Farwell, M. D.; Mitchell, T. C.; Schuchter, L. M.; Ziolkowska, M.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Adaptive neoadjuvant chemotherapy guided by (18)F-FDG PET in resectable non-small cell lung cancers: The NEOSCAN trial
    Journal Article

    Chaft, J. E.; Dunphy, M.; Naidoo, J.; Travis, W. D.; Hellmann, M.; Woo, K.; Downey, R.; Rusch, V.; Ginsberg, M. S.; Azzoli, C. G.; more...
    Journal of Thoracic Oncology (2016)

    Fulltext@MSK | Save
  • NEOSCAN: Phase II trial of neoadjuvant chemotherapy for resectable lung cancers with switch to chemo alternative in (18)F-FDG PET nonresponders
    Meeting Abstract

    Kris, M. G.; Hellmann, M. D.; Naidoo, J.; Dunphy, M.; Sima, C. S.; Downey, R. J.; Travis, W. D.; Azzoli, C. G.; Chaft, J. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase II study of 18f-FDG PET guided optimization of neoadjuvant chemotherapy for resectable non-small cell lung cancer
    Meeting Abstract

    Chaft, J. E.; Hellmann, M. D.; Dunphy, M.; Jappe, W.; Sima, C. S.; Downey, R. J.; Travis, W. D.; Azzoli, C. G.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save